Senior Driving Simulation Training for Subjective Cognitive Decline and Mild Cognitive Impairment (SDST)

May 29, 2023 updated by: Huie-Ling Chiu, Taipei Medical University

Evaluation of Senior Driving Simulation Training on Executive Function, Cognitive Promotion and EEG in Subjective Cognitive Decline and Mild Cognitive Impairment

This study aims to establish the Senior Driving Simulation Training (SDST) for Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI), and explore the effectiveness of Senior Driving Simulation Training (SDST) on the executive function, cognitive function and EEG.

Study Overview

Detailed Description

Driving behavior is a high cognitively demanding task, and whether the Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI) can continue to drive is an important issue. This study will develop the Taiwan version of innovative, immediate feedback and environmentally safe Senior Driving Simulation Training (SDST). This study aims to establish the Senior Driving Simulation Training (SDST) for Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI), and explore the effectiveness of Senior Driving Simulation Training (SDST) on the executive function, cognitive function and EEG. The investigators intend to conduct a single-blind randomized controlled trial using a two-arm parallel-group design. Participants will be randomized by the permuted block randomization, block size of 4, into an experimental group (Senior Driving Simulation Training: 30-mins training session two times per week for 5 weeks, with a total of 10 sessions) or a control group (Waiting list). The investigators plan to blind the therapists and outcome assessors to maintain the blinding methods' quality. The primary outcome indicators are mental set-shifting, working memory, and inhibition. The secondary outcome indicators are cognitive function and EEG. The investigators also evaluate visual awareness and simulator sickness. The short-term (immediate post-test) and the long-term (3, 6, and 12 months) effectiveness of the intervention on individual outcome measures will be analyzed by the generalized estimating equation. The investigators also plan to use the secondary data analysis methods to investigate the relationship between objective indicators of a driving simulator, executive function, cognitive function, EEG, visual awareness, and simulator sickness. Furthermore, the investigators will analyze the trend of EEG while the participants conducting the training, and complete the psychometric properties of the Chinese version of the Cognitive Change Index (C-CCI). This will be the first senior driving simulation training (SDST) for Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI) in Taiwan. Results of the current study will provide valuable information on driving safety decisions and apply to promote the advanced driving policies.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 110
        • Taipei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Subjective cognitive decline( AD-8 scale ≥1 point).
  • Mild cognitive impairment (AD-8 scale ≥ 2 points), and MMSE> 24 points, can maintain personal daily activity function.
  • Can communicate in Chinese or Taiwanese.
  • At least 60 years of age.
  • Those with a car driving license.
  • No physical impairment.
  • In addition to the above conditions, participants must be voluntary and signed informed consent.

Exclusion Criteria:

  • Dementia, diagnosed by a physician and in compliance with ICD-10.
  • Significant mental illness or communication impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Senior Driving Simulation Training
The experimental group (Senior Driving Simulation Training: 30-mins training session two times per week for 5 weeks, with a total of 10 sessions) .
Other: Control Group
Waiting-list
The control group is waiting list control. They will also receive the (Senior Driving Simulation Training) after all research is done.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental set shifting, measured by Wisconsin Card Sorting Test
Time Frame: immediate post-test
Mental set shifting is one of the sub-categories of executive function
immediate post-test
Change from Baseline Mental set shifting, measured by Wisconsin Card Sorting Test at 3 months
Time Frame: 3 months follow-up
Mental set shifting is one of the sub-categories of executive function
3 months follow-up
Working memory, measured by Digit span test
Time Frame: immediate post-test
Working memory is one of the sub-categories of executive function
immediate post-test
Change from Baseline Working memory, measured by Digit span test at 3 months
Time Frame: 3 months follow-up
Working memory is one of the sub-categories of executive function
3 months follow-up
Inhibition, measured by the Stroop Color and Word Test
Time Frame: immediate post-test
Inhibition is one of the sub-categories of executive function
immediate post-test
Change from Baseline Inhibition, measured by the Stroop Color and Word Test at 3 months
Time Frame: 3 months follow-up
Inhibition is one of the sub-categories of executive function
3 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive function measured by Montreal Cognitive Assessment
Time Frame: immediate post-test
Cognitive function measured by Montreal Cognitive Assessment
immediate post-test
Cognitive function measured by Cognitive Change Index(C-CCI)
Time Frame: immediate post-test
Cognitive function measured by Cognitive Change Index(C-CCI)
immediate post-test
Change from Baseline cognitive function by Montreal Cognitive Assessment at 3 months
Time Frame: 3 months follow-up
Change from Baseline cognitive function by Montreal Cognitive Assessment at 3 months
3 months follow-up
Change from Baseline cognitive function by Cognitive Change Index(C-CCI)at 3 months
Time Frame: 3 months follow-up
Change from Baseline cognitive function by Cognitive Change Index(C-CCI)at 3 months
3 months follow-up
EEG
Time Frame: immediate post-test
EEG power in delta, theta, alpha, and beta band
immediate post-test
Change from Baseline EEG at 3 months
Time Frame: 3 months follow-up
EEG power in delta, theta, alpha, and beta band
3 months follow-up
Visual awareness measured by CANTAB
Time Frame: immediate post-test
Visual awareness measured by CANTAB
immediate post-test
Visual awareness measured by trail making test
Time Frame: immediate post-test
Visual awareness measured by trail making test
immediate post-test
Change from Baseline visual awareness by CANTAB at 3 months
Time Frame: 3 months follow-up
Visual awareness measured by CANTAB
3 months follow-up
Change from Baseline visual awareness by trail making test at 3 months
Time Frame: 3 months follow-up
Change from Baseline visual awareness by trail making test at 3 months
3 months follow-up
simulator sickness
Time Frame: immediate post-test
Simulator Sickness Questionnaire (SSQ). The 16-item SSQ will be used to assess participants' sickness levels. This is the 4-point Likert scale (0 - "None" to 3 - "Severe"), and the higher total score reflects more severe sickness.
immediate post-test
Usability
Time Frame: immediate post-test
The System Usability Scale (SUS) will be used to access the usability, this scale consists of 10 items, and the higher total score reflects better usability.
immediate post-test
Acceptance
Time Frame: immediate post-test
The Technology Acceptance for Older Adults Scale will be used to access the acceptance, this scale consists of 17 items, and the higher total score reflects better acceptance.
immediate post-test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Huei-Ling Chiu, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 28, 2022

Primary Completion (Actual)

January 1, 2023

Study Completion (Actual)

May 28, 2023

Study Registration Dates

First Submitted

April 30, 2022

First Submitted That Met QC Criteria

May 14, 2022

First Posted (Actual)

May 18, 2022

Study Record Updates

Last Update Posted (Actual)

June 1, 2023

Last Update Submitted That Met QC Criteria

May 29, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe